Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 07-2000 | 04-2000 | 01-2000 | |
| Cash Flows From Operating Activities | |||
| Net Income | 780,900 | 771,300 | 53,100 |
| Depreciation Amortization | 97,400 | 57,700 | 29,600 |
| Income taxes - deferred | -2,500 | -1,600 | N/A |
| Accounts receivable | -193,000 | -103,200 | 19,100 |
| Accounts payable and accrued liabilities | 76,500 | 19,300 | -20,500 |
| Other Working Capital | 192,600 | 206,100 | -50,300 |
| Other Operating Activity | -890,300 | -916,000 | 2,600 |
| Operating Cash Flow | $61,600 | $33,600 | $33,600 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -230,400 | -115,900 | -49,000 |
| Net Acquisitions | -314,100 | -56,300 | -18,000 |
| Purchase Of Investment | N/A | N/A | 23,200 |
| Sale Of Investment | 185,200 | 98,000 | 5,400 |
| Investing Cash Flow | $-359,300 | $-74,200 | $-38,400 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | 32,200 | -23,000 | -26,300 |
| Common Stock Issued | 200,700 | 116,900 | 50,700 |
| Financing Cash Flow | $232,900 | $93,900 | $24,400 |
| Exchange Rate Effect | -3,100 | -2,200 | -600 |
| Beginning Cash Position | 279,000 | 279,000 | 279,000 |
| End Cash Position | 211,100 | 330,100 | 298,000 |
| Net Cash Flow | $-67,900 | $51,100 | $19,000 |
| Free Cash Flow | |||
| Operating Cash Flow | 61,600 | 33,600 | 33,600 |
| Capital Expenditure | -230,400 | -115,900 | -49,000 |
| Free Cash Flow | -168,800 | -82,300 | -15,400 |